JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M001534200 on April 18, 2000

J. Biol. Chem., Vol. 275, Issue 29, 21928-21938, July 21, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/29/21928    most recent
M001534200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Easton, R. L.
Right arrow Articles by Dell, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Easton, R. L.
Right arrow Articles by Dell, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pregnancy-associated Changes in the Glycosylation of Tamm-Horsfall Glycoprotein

EXPRESSION OF SIALYL LEWISx SEQUENCES ON CORE 2 TYPE O-GLYCANS DERIVED FROM UROMODULIN*

Richard L. EastonDagger , Manish S. Patankar§, Gary F. Clark§, Howard R. MorrisDagger ||, and Anne DellDagger **

From the Dagger  Department of Biochemistry, Imperial College of Science, Technology, and Medicine, London SW7 2AY, United Kingdom and the § Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia 23501

Received for publication, February 23, 2000, and in revised form, April 17, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Tamm-Horsfall glycoprotein (THP) is a major glycoprotein associated with human urine that binds pro-inflammatory cytokines and also inhibits in vitro T cell proliferation induced by specific antigens. THP derived from human pregnancy urine (designated uromodulin) has previously been shown to be 13-fold more effective as an inhibitor of antigen-induced T cell proliferation than THP obtained from other sources. Structural analysis of human THP and uromodulin has for the first time revealed that these glycoproteins are O-glycosylated. THP from nonpregnant females and males expresses primarily core 1 type O-glycans terminated with either sialic acid or fucose but not the sialyl Lewisx epitope. By contrast, the O-glycans linked to uromodulin include unusual core 2 type glycans terminated with one, two, or three sialyl Lewisx sequences. The specific association of these unusual carbohydrate sequences with uromodulin could explain its enhanced immunomodulatory effects compared with THP obtained from males and nonpregnant females. Analysis of THP from one of the pregnant females 2 months postpartum showed a reversion of the O-glycan profile to that found for a non-pregnant female. These data suggest that the glycosylation state of uromodulin could be under the regulation of steroidal hormones produced during pregnancy. The significant physiological implications of these observations are discussed.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Tamm-Horsfall glycoprotein (THP)1 is the most abundant glycoprotein in human urine (1, 2). The precise physiological role of THP remains enigmatic, despite considerable investigation of this glycoprotein over the past 50 years. THP was shown to block hemagglutination induced by influenza, mumps, and Newcastle disease viruses (1, 2). THP has been postulated to be essential for protecting the kidneys from bacterial infections (3, 4). THP has also been implicated as a potential component necessary for maintenance of the electrolyte balance in the nephron (5). In addition, THP may also play a significant role in several pathological conditions involving the kidney, including acute renal failure, urinary tract infection, stone formation, and interstitial nephritis (6).

In 1973, two studies (7, 8) suggested that human chorionic gonadotropin isolated from pregnancy urine suppressed specific immune activities in vitro. However, this immunosuppressive activity turned out to be due to a contaminant of the human chorionic gonadotropin preparation (9, 10). Muchmore and Decker (11) later used lectin affinity chromatography, gel separation, and isoelectric focusing to purify a glycoprotein from human pregnancy urine that mediated this immunosuppressive activity. They designated this glycoprotein "uromodulin" to account for its origin and its immunomodulatory activities. Amino acid sequence analysis (12, 13) revealed that uromodulin represented THP glycoforms produced during pregnancy.

Uromodulin was initially shown to inhibit antigen-induced T cell proliferation at relatively low concentrations (11). Subsequent investigations by Muchmore and colleagues (14-16) indicated that uromodulin could also bind to recombinant interleukin-1 and recombinant interleukin-2 and recombinant tumor necrosis factor via its oligosaccharide sequences. The glycans associated with uromodulin have been proposed to be essential for its immunosuppressive and cytokine binding activities (12, 14-16). By contrast, another study indicated that both THP and uromodulin would bind to IL-1 and tumor necrosis factor but only after these cytokines were either denatured or immobilized on solid surfaces (17). However, a more recent study indicates that oligosaccharides associated with THP block IL-1 binding to immune effector cells and to an IL-1-dependent cell line (18). The investigators in this study (18) also provided strong evidence that N-linked glycans terminated with GalNAc, and a sulfate group mediates these immunomodulatory activities in vitro. This demonstration that THP or its derivative oligosaccharides can also mediate cytokine bindings, and specific responses in immune cells suggests that this glycoprotein is functionally equivalent to uromodulin. However, Muchmore and co-workers (12) suggested that uromodulin was a 13-fold more active inhibitor of antigen-specific T cell proliferation than THP. The observation that THP and uromodulin express identical polypeptide sequences suggests that pregnancy-related changes in post-translational modifications could be responsible for their differential immunosuppressive activities.

The present investigation was undertaken to determine if THP and uromodulin are differentially glycosylated. Several pregnancy associated changes in the glycosylation of THP were found, the most notable being that uromodulin specifically expresses unusual core 2 type O-linked glycans terminated with up to three sialyl Lewisx sequences.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Purification of THP/Uromodulin-- THP or uromodulin was purified from urine from a range of individuals. Each sample was prepared individually. THP was isolated using the same procedure originally employed by Tamm and Horsfall (1). The urine sample was adjusted to pH 7.0 using sodium hydroxide. Sodium chloride was then added and dissolved to give a final concentration of 0.58 M NaCl. The sample was then left at 4 °C for 5 h followed by centrifugation at 1000 rpm for 30 min. The supernatant was removed and the precipitate resuspended in 2 ml of 0.58 M sodium chloride. The sample was then centrifuged at 4000 rpm for 15 min. The supernatant was again removed and the precipitate resuspended in 2 ml of water. This purified THP/uromodulin was then transferred into a regenerated cellulose dialysis membrane with 12-14-kDa nominal molecular weight cutoff (Cellu-Sep) and dialyzed against 4 × 2.5 liters of water at 4 °C, the water being changed at 12-h intervals for 2 days. After dialysis the THP/uromodulin was lyophilized.

Reduction and Carboxymethylation-- THP/uromodulin was subject to reduction and carboxymethylation of S---S-bridged cysteine residues as described previously (19) with three modifications. First, the reduction was performed under a nitrogen atmosphere; second, the iodoacetic acid incubation was performed under a nitrogen atmosphere at 37 °C; and third, the reaction was terminated and desalted by dialysis against 4 × 2.5 liters of 50 mM ammonium bicarbonate, pH 8.5, at 4 °C for 2 days, the dialysate being changed every 12 h. After dialysis the sample was lyophilized.

Tryptic Digestion-- THP/uromodulin was digested with trypsin using a 1:100 w/w ratio of trypsin (EC 3.4.21.4, Sigma) to THP/uromodulin as described (19). The incubation period for the digestion was 5 h. Following termination of the digestion the sample was lyophilized.

Peptide N-Glycosidase F Digestion-- THP/uromodulin was digested with 3 units of peptide N-glycosidase F (EC 3.5.1.52, Roche Molecular Biochemicals) as described (19). The reaction was terminated by lyophilization, and the released N-glycans were separated from peptides and O-glycopeptides by Sep-Pak as described (19). Prior to loading onto the conditioned Sep-Pak the sample was dissolved in 200 µl of 5% acetic acid.

Digestion with Vibrio cholerae Neuraminidase-- Tryptic O-glycopeptides from uromodulin, present in the 20% 1-propyl alcohol Sep-Pak fraction, were dissolved in 50 mM ammonium acetate, pH 4.5, and digested with 25 milliunits of V. cholerae neuraminidase (EC 3.2.1.18, Roche Molecular Biochemicals) for 24 h at 37 °C. Following digestion the sample was lyophilized.

Reductive Elimination-- THP/uromodulin was subject to reductive elimination as described (19). Following termination of the reaction using glacial acetic acid, the 20 and 40% 1-propyl alcohol fractions were combined prior to Dowex chromatography.

Chemical Defucosylation-- The released O-glycans were dissolved in 50 µl of hydrofluoric acid (Sigma) and placed on ice for 30 min. The reaction was terminated by drying under a stream of nitrogen.

Periodate Cleavage-- A solution of 2 mM sodium periodate in 100 mM ammonium acetate, pH 6.5, was prepared, wrapped in foil, and placed in the fridge for 1 h. Released, dried O-glycans were then dissolved in 50 µl of this reagent, wrapped in foil, and placed on ice in the fridge overnight. The reaction was terminated by the addition of 2 µl of ethylene glycol and lyophilized. The products of periodate cleavage were reduced using 200 µl of a 10 mg/ml solution of sodium borohydride in 2 M ammonium hydroxide. The reaction was allowed to proceed at room temperature for 2 h. The reaction was terminated by addition of glacial acetic acid until all the sodium borohydride had been neutralized. The sample was subject to Dowex chromatography, borate removal, permethylation, and Sep-Pak clean up using an acetonitrile gradient as described (19).

Chemical Derivatization for FAB-MS and Gas Chromatography-MS Analysis-- Released glycans were permethylated using the sodium hydroxide procedure and purified by Sep-Pak using an acetonitrile gradient as described (19). Partially methylated alditol acetates were prepared from the permethylated glycans as described (20) and analyzed by gas chromatography-MS.

Mass Spectrometric Analyses-- Fast atom bombardment-mass spectrometric analysis of permethylated glycans was performed using a ZAB 2SE 2FPD double-focusing mass spectrometer fitted with a cesium ion gun operating at 30 kV. The matrix used was monothioglycerol, and all samples were dissolved in methanol prior to loading. Data were collected and analyzed using VG Opus® software. Linkage analysis of partially methylated alditol acetates was carried out using an MD 800 gas chromatography-mass spectrometer. Chromatographic separation was achieved using a 30 m × 0.25 mm inner diameter RTX-5 fused silica capillary column (Restek Corp.). The sample was dissolved in hexanes and injected onto the column at 65 °C. The column was held at this temperature for 1 min and then increased to 290 °C at a rate of 8 °C per min.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Structural Analysis Strategy-- THP or uromodulin were isolated as described under "Experimental Procedures" from urine samples of three males, three non-pregnant females, and two pregnant females. Additionally THP was isolated from one of the pregnant females 2 months postpartum. All samples exhibited a single band on SDS-polyacrylamide gel electrophoresis at about 90 kDa (data not shown). Peptide mapping by FAB-MS confirmed the presence of the THP polypeptide (data not shown). Putative O-glycans were released by reductive elimination, permethylated, and purified on a Sep-Pak cartridge that was eluted with a stepwise gradient of aqueous acetonitrile. The permethylated glycans, which were recovered in the 35 and 50% acetonitrile fractions, were analyzed by FAB-MS and linkage analysis. Under the conditions used for reductive elimination, a portion of the N-glycans is also released. Their presence was taken into account in the interpretation of the FAB and linkage data.

Analysis of Glycans Released from Male THP by Reductive Elimination-- FAB-MS analyses of the 35% acetonitrile fractions from male THP showed several low molecular weight O-glycans, the most abundant of which (m/z 895 and 1256) were present in all three samples (Fig. 1 and Table I). These masses correspond to compositions NeuAcHexHexNAcitol and NeuAc2HexHexNAcitol, respectively, and are consistent with sialylated and desialylated T-antigen structures (NeuAcalpha 2-3Galbeta 1-3GalNAc and NeuAcalpha 2-3Galbeta 1-3(NeuAcalpha 2-6)GalNAc). These simple core 1 type glycans are found in many glycoproteins including glycophorin, erythropoietin, and plasminogen. There is some variation between individuals with respect to the relative abundance of the above two glycans and the compositions of minor structures present (Table I). For example, m/z 1140 (NeuAcHexHexNAcHexNAcitol) was detected in only two samples. This glycan probably carries the Sda antigen (GalNAcbeta 1-4(NeuAcalpha 2-3)Galbeta 1-)which is known to be present on the antennae of THP N-glycans (21). The 50% acetonitrile fractions showed molecular ions attributable to high mannose N-glycans (Fig. 1b and Table I). These are readily identifiable because of their unique compositions and because they exhibit pairs of molecular ions separated by 16 mass units due to the incomplete reduction that is characteristic of N-glycans released under reductive elimination conditions. O-Glycans, in contrast, are fully reduced under the conditions employed in our experiments. No significant signals corresponding to O-glycans were observed in the 50% fraction.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   FAB mass spectra of the reductively eliminated glycans of THP/uromodulin isolated from a single male. Glycans were permethylated and subjected to Sep-Pak clean-up. a, 35% acetonitrile fraction; b, 50% acetonitrile fraction. Signals are assigned in Table I. The A-type fragment ion at m/z 1070 is most likely derived from contaminating N-glycans (see text) that are known to be rich in the Sda sequence (21).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Assignments of molecular ([M + Na]+) and A-type fragment ions detected in the FAB-mass spectra of permethylated glycans derived from three male (M1-M3) and three female (F1-F3) THP samples
Major components are shown by check marks and minor components by check marks in parentheses. The dashes indicate the absence of the relevant peak in the spectrum.

Analysis of Glycans Released from Female THP by Reductive Elimination-- Fig. 2 and Table I show FAB data obtained from the analysis of THP from a single female. Data from a further two females are also shown in Table I. Comparison with the male data allows the following conclusions to be drawn. (i) The two major glycans observed in the male (NeuAc1,2HexHexNAcitol) are also found in female THP, but their abundance varies significantly between individuals and is generally lower in females than males. (ii) Like the male, the non-pregnant female appears to contain relatively simple O-glycans containing no more than six sugar residues. (iii) In two of the samples analyzed, an abundant signal at m/z 1157 was detected corresponding to FucHex2HexNAcHexNAcitol. One of these two samples also exhibited a minor signal corresponding to the presence of a second fucose residue (m/z 1331). These glycans probably contain Lewisx/a structures (Galbeta 1-4/3(Fucalpha 1-3/4)GlcNAcbeta 1), evidence for which is provided by a fragment ion at m/z 638 (A-type fragment ion of composition FucHexHexNAc+).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   FAB mass spectra of the reductively eliminated glycans of THP/uromodulin isolated from a single female. Glycans were permethylated and subjected to Sep-Pak clean-up. a, 35% acetonitrile fraction; b, 50% acetonitrile fraction. The signals at m/z 873 and 1234 represent the protonated form of m/z 895 and 1256, respectively. The signals at m/z 897, 947, 1242, and 1258 are contaminants.

Uromodulin Contains O-Glycans Not Present in THP-- Fig. 3a and Table II show FAB data obtained from the analysis of the 50% Sep-Pak fraction of permethylated glycans from uromodulin obtained from a single pregnant female. Data from a second pregnant female are also shown in Table II. The data show striking differences when compared with THP. The most notable feature is the presence of major molecular ions corresponding to large O-glycans rich in fucose and sialic acid which are completely absent in the THP samples. The most abundant of these components are observed at m/z 1519 (NeuAcFucHex2HexNAcHexNAcitol), m/z 1880 (NeuAc2FucHex2HexNAcHexNAcitol), and m/z 2504 (NeuAc2Fuc2Hex3HexNAc2HexNAcitol). Weaker signals are present at higher mass that correspond to larger O-glycans carrying additional fucosyl and sialyl residues up to a composition of NeuAc3Fuc3Hex4HexNAc3HexNAcitol (m/z 3487). The abundant signal at m/z 999 (NeuAcHexHexNAcFuc+) is consistent with the presence of either sialyl Lewisx or sialyl Lewisa. The majority of the putative Lewis epitopes are sialylated since a signal at m/z 638 (not shown), representing FucHexHexNAc+, is minor compared with m/z 999. No signals were detected for fragment ions corresponding to lactosamine repeats, indicating that the higher mass structures are most likely produced by branching of O-glycans rather than chain elongation.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 3.   FAB mass spectra of the reductively eliminated glycans of THP/uromodulin isolated from a single pregnant female. Glycans were permethylated and subjected to Sep-Pak clean-up. a, 50% acetonitrile fraction during pregnancy; b, 50% acetonitrile fraction 2 months post-partum. The minor signals near m/z 2600 and 3300 in b correspond to N-glycans as exemplified by the presence of twin peaks separated by 16 mass units.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Assignments of the molecular ([M + Na]+) and A-type fragment ions detected in the FAB-mass spectra of permethylated glycans derived from uromodulin
Major components are shown by check marks and minor components by check marks in parentheses. The dashes indicate the absence of the relevant peak in the spectrum.

Modification of O-Glycan Profile following Parturition-- Analysis of THP/uromodulin isolated from the first pregnant female 2 months after birth of a male baby showed a dramatic change in the O-glycan profile (Fig. 3b). Notably the sialylated and fucosylated O-glycans observed in uromodulin had virtually disappeared (for example, compare m/z 1519, 1880, and 2504 in Fig. 3, a and b), whereas the profile of small O-glycans that eluted in the 35% Sep-Pak fraction was largely unaffected and was similar to the non-pregnant state (Fig. 4, a and b).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   FAB mass spectra of the reductively eliminated glycans of THP/uromodulin isolated from a single pregnant female following permethylation and Sep-Pak clean-up. a, 35% acetonitrile fraction during pregnancy; b, 35% acetonitrile fraction 2 months after pregnancy. The signals at m/z 901 and 973 in a are contaminants.

Confirmation of the Presence of Fucose in Uromodulin O-Glycans-- Reductively eliminated glycans from uromodulin were subjected to hydrofluoric acid defucosylation, and the products of the reaction were permethylated and analyzed by FAB-MS after Sep-Pak purification. The data show that the signals attributed to fucose containing O-glycans (Table II) have either disappeared or are considerably reduced in intensity (compare Fig. 5, a and b). New signals are present (Fig. 5b) consistent with loss of fucose from the original structures such as m/z 1344 (loss of fucose from m/z 1519) and m/z 1706 (loss of fucose from m/z 1880). The fragment ion originally present at m/z 999, representing a possible sialyl Lewis epitope, has also virtually disappeared. The signal at m/z 825 (NeuAcHexHexNAc+ fragment ion) is more intense than was originally detected. This product is expected following the defucosylation of the putative sialyl Lewis epitope.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 5.   FAB-mass spectra of the reductively eliminated glycans of THP/uromodulin isolated from a single pregnant female before and after treatment with hydrogen fluoride. Both samples were permethylated and cleaned up by Sep-Pak. a, 50% acetonitrile fraction prior to treatment; b, 50% acetonitrile fraction following treatment. The signals at m/z 901, 1105, 1211, and 1309 are contaminants.

Desialylation of Uromodulin O-Glycans-- Tryptic glycopeptides were desialylated using V. cholerae sialidase, and glycans were released by reductive elimination, permethylated, and analyzed by FAB-MS. The data showed the loss of signals with compositions consistent with the presence of sialic acid (compare Fig. 6, a and b). New signals were observed at the expected desialylated masses. Thus loss of one and two sialic acids, respectively, from m/z 1519 and 1880 yields m/z 1157, whereas similar losses from m/z 2142 and 2504 yields m/z 1781. The new signals at m/z 2230 and 2404 represent desialylation of the higher mass structures shown in Fig. 6a, specifically m/z 2230 is derived from m/z 2952 and 3313, and m/z 2404 is derived from m/z 3126 and 3487. The sialyl Lewisx/a fragment ion (m/z 999) disappeared concomitant with a significant increase in the signal at m/z 638 (FucHexHexNAc+), consistent with the loss of sialic acid from this epitope.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 6.   FAB-mass spectra of the reductively eliminated glycans of uromodulin upon treatment of glycopeptides with Arthrobacter ureafaciens sialidase. Following the reaction the glycans were released from the glycopeptides by reductive elimination, permethylated, and purified by Sep-Pak. a, uromodulin glycans prior to treatment with sialidase; b, uromodulin glycans after treatment with sialidase. The signals at m/z 697, 901, 1105, 1211, 1309, 1513, 1718, and 1922 are contaminants.

Periodate Cleavage Defines Core Types and Antennae Backbones of Uromodulin O-Glycans-- Mild periodate oxidation cleaves linear sections of sugar structures if vicinal hydroxyl groups are present. Thus, with respect to the O-glycans of uromodulin, the GalNAcitol and any sialic acids are sensitive to this reagent. Reductively eliminated glycans were subjected to mild periodate oxidation followed by reduction, permethylation, Sep-Pak clean up, and FAB-MS analysis. The FAB data for the 35 and 50% Sep-Pak fractions (Fig. 7, a and b, respectively, and Table III) showed molecular ions consistent with periodate cleavage of the GalNAcitol residue producing two distinct sets of products, one containing the C-1 to C-4 carbons of the GalNAcitol (denoted C-4) attached to the 3-linked antenna(e), and the other containing the C-5 and C-6 carbons (denoted C-2) attached to the 6-linked antenna(e). Thus, m/z 719, 1069, 1342, 1587, 1791, 1967, 2065, and 2240 are attributable to 3-linked antennae because their masses are consistent with the presence of a C-4 moiety at the reducing end (Table III). Similarly, m/z 562, 736, 835, and 1009 are consistent with 6-linked antennae (attached to the C-2 moiety). From these data it is evident that the sialyl Lewisx/a epitope is present on both 3-linked (m/z 1342) and 6-linked (m/z 1009) antennae, although the significantly larger signal at m/z 1009 compared with m/z 1342 indicates that attachment to carbon 6 is more common in these smaller structures. The higher mass signals corresponding to 3-linked antennae have compositions consistent with the possible presence of lactosamine repeats. However, the absence of A-type fragment ions characteristic of polylactosamine sequences in the spectra of the intact glycans (see, for example Fig. 3a) suggests that polylactosamine structures are unlikely to be present. Consequently 3-linked antennae of compositions NeuAcFuc2Hex3HexNAc2-C-4, NeuAc2FucHex3HexNAc2-C-4, and NeuAc2Fuc2Hex3HexNAc2-C-4 are likely to be branched. Their compositions are consistent with the presence of two sialyl Lewisx epitopes.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 7.   FAB-mass spectra of the reductively eliminated glycans from uromodulin following treatment with periodate. After periodate treatment the glycans were reduced, permethylated, and purified by Sep-Pak. a, 35% acetonitrile fraction; b, 50% acetonitrile fraction. The majority of signals are assigned in Table III. Signals at m/z 1552, 1757, and 1961 correspond to reduced high mannose glycans (Man5 to Man7, respectively) whose terminal GlcNAcitol has been cleaved between carbons 5 and 6 by the periodate treatment. The signal at m/z 1800 corresponds to residual Man6GlcNAcGlcNAcitol.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Assignments of molecular ions ([M + Na]+) of reductively eliminated uromodulin O-glycans following periodate treatment, reduction, and permethylation
See text for explanation of C-2 and C-4. Note that each of the NeuAc residues lacks carbons 8 and 9 as a result of the periodate cleavage.

Linkage Analysis of Reductively Eliminated Uromodulin Glycans-- Linkage analysis data for uromodulin are shown in Table IV. Notable features of the linkage data are as follows: (i) 3,6-GalNAcitol is significantly more abundant than 3-GalNAcitol, which is consistent with core 2 type structures being dominant in pregnant samples and is significantly reduced postpartum; (ii) the presence of 3,6-Gal supports the periodate data that provided evidence for the existence of branched structures, and this component was very minor post-pregnancy in accord with the FAB data showing loss of the high molecular weight O-glycans; (iii) the absence of detectable levels of 6-Gal indicates that the sialic acids are attached at the 3-position of galactose; this was confirmed by linkage analysis performed after V. cholerae desialylation that showed a loss of 3-linked galactose and an increase of terminal galactose; (iv) the presence of 3,4-GlcNAc, which disappears after HF defucosylation without the concomitant appearance of 3-linked GlcNAc, confirms that sialyl Lewisx and not sialyl Lewisa is present in the O-glycans; (v) the terminal GalNAc is supportive of the possible presence of the Sda antigen in a minority of glycans; (vi) the variously linked mannoses are derived from the "contaminating" N-glycans.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Data from linkage analysis of the partially methylated alditol acetates obtained from reductively eliminated glycans of uromodulin
The 50% acetonitrile fractions from Sep-Pak purifications of permethylated glycans were hydrolyzed, reduced, acetylated, and analyzed by gas chromatography-MS.

Structures of the High Molecular Weight O-Glycans in Uromodulin-- Taking into consideration the FAB-MS, linkage, exoglycosidase, periodate, and defucosylation data, we arrive at the following structural conclusions: (i) uromodulin carries a range of O-glycans that are not present in THP; (ii) these glycans are rich in sialyl Lewisx and the majority have the core 2 type (Galbeta 1-3(GlcNAcbeta 1-6)GalNAc), in contrast with THP which is mostly core 1 type; (iii) the periodate data suggest that the 6-linked antenna has four possible sequences viz. Gal-GlcNAc, NeuAc-Gal-GlcNAc, Lewisx, and sialyl Lewisx; in contrast the 3-linked antennae show significantly greater heterogeneity with at least eight structures being observed; (iv) the largest glycan observed is a tetradecamer whose composition (NeuAc3Fuc3Hex4HexNAc4) is consistent with the presence of three sialyl Lewisx moieties. Structures taking account of these conclusions are summarized in Fig. 8.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 8.   Proposed structures of the unusual O-glycans present on uromodulin. Linkage analysis indicates that the branched Gal is substituted at positions 3 and 6.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The primary goal of the present study was to determine if any major changes in the glycosylation of THP occurs during human pregnancy. To carry out this investigation, uromodulin was isolated from human pregnancy urine by the salt precipitation method previously employed to isolate THP from non-pregnant females and males (2). This consistent approach to the isolation of THP and uromodulin is important, because uromodulin was originally isolated from human pregnancy urine by a procedure that included lectin affinity chromatography (11). This distinction is also significant because THP and uromodulin are often used synonymously in many studies (22). It is abundantly clear from the present study that uromodulin isolated from human pregnancy urine represents a discrete set of THP glycoforms that are different from those expressed in nonpregnant females and males.

The present results provide convincing evidence that both uromodulin and THP express O-glycans. This observation differs from the result of a previous study suggesting that THP or uromodulin are devoid of such sequences (23). One possible explanation for this discrepancy could be the imprecise methods employed in this previous investigation. Afonso and co-workers (23) digested THP with Pronase to generate glycopeptides that were then analyzed on gel filtration columns. It is very difficult to obtain exact structural definition using such an approach. Moreover, at the time that their study was performed, O-glycan expression was often detected by measuring the amount of GalNAc present in glycopeptide fractions. The expression of the Sda antigen on the terminal ends of N-glycans associated with both uromodulin and THP precluded this monosaccharide analysis of glycopeptides as an indicative method for detecting O-glycan expression.

The N-linked oligosaccharides associated with THP and uromodulin have been the focus of numerous structural studies employing definitive biophysical analysis (21, 24-27). There are eight potential N-linked glycosylation sites, of which seven (Asn-52, Asn-56, Asn-208, Asn-251, Asn-298, Asn-372, and Asn-489) are occupied (27). Biantennary, triantennary, and tetraantennary complex type glycans constitute most of the N-linked oligosaccharides. High mannose type glycans are attached at only one site (Asn-251), where they represent 67% of the total glycans linked at this position (27). The complex type glycans are terminated with the following antennae attached to core mannosyl residues: Galbeta 1-4GlcNAc, NeuAcalpha 2-3Galbeta 1-4GlcNAc, NeuAcalpha 2-6Galbeta 1-4GlcNAc, Gal3Sbeta 1-4GlcNAc, and GalNAc4Sbeta 1-4GlcNAc (21). Polylactosamine type sequences are also attached to some of the N-glycans associated with THP (28). However, this expression is a donor-specific feature not found on all samples of this glycoprotein (25).

Rigorous methods of biophysical analysis have now been used to confirm that O-glycans are also linked to THP. Both males and non-pregnant females express very simple mono- and desialylated derivatives of core 1 type sequences on THP. By contrast, the O-glycans derived from uromodulin are primarily core 2 O-linked glycans that are further branched on the beta 1-3-linked Gal to generate sophisticated structures expressing up to three sialyl Lewisx sequences (Fig. 8). Analysis of maternal THP 2 months postpartum indicates that the synthesis of these unusual core 2 type O-glycans is strictly pregnancy-related.

This specific association of the sialyl Lewisx sequence with uromodulin could be particularly significant, especially given the previously reported immunomodulatory activities of this glycoprotein. The sialyl Lewisx antigen (NeuAcalpha 2-3Galbeta 1-4[Fucalpha 1-3]GlcNAc) was originally identified as a differentiation antigen associated with neutrophils and monocytes (29, 30). Several groups (31-35) demonstrated that oligosaccharides and glycolipids terminated with the sialyl Lewisx sequence serve as ligands for E-, P-, and L-selectin-mediated binding. However, only E-selectin displays preferential adhesion to the sialyl Lewisx sequence under physiological circumstances. P-selectin binding to its primary glycoprotein ligand (PSGL-1) requires the co-presentation of the sialyl Lewisx sequence and a specific tyrosine sulfate residue on an NH2-terminal mucin-like domain (36, 37). L-selectin forms a tighter interaction with sulfated forms of the sialyl Lewisx sequence (38). It is noteworthy that most of the E- and L-selectin ligands on the surface of murine neutrophils are carried on core O-glycans, based on results obtained with core 2 GlcNAc transferase knockout mice (39).

It is also significant in this context to note that neutrophils have been shown to interact with both THP and uromodulin in in vitro assay systems. Neutrophils specifically bind to microtiter plates coated with THP (40). This interaction is calcium-dependent, requires metabolically active cells, and is inhibited by soluble THP. However, this binding was also partially inhibited by the peptide sequence YRGDG, suggesting that integrin-mediated adhesions could play a role in this interaction (40). Yu and co-workers(41) reported that THP purified from normal human pregnancy urine increases phagocytosis, complement receptor expression, and arachidonic acid metabolism of neutrophils. These investigators suggested that this glycoprotein could play a significant role in the defense mechanisms of the urinary tract.

The data presented in this paper provide a new impetus for re-examining the immunomodulatory effects of THP versus uromodulin. In particular, the current results suggest a potential structural basis for the differential activity of uromodulin and THP in the antigen-induced T cell proliferation assay system reported by Muchmore and colleagues (12) over a decade ago. These investigators relied upon affinity chromatography on concanavalin A-agarose to isolate uromodulin, whereas in this study the salt precipitation method was employed (1). This difference could potentially impact immunological assays. On the other hand, a very substantial percentage of uromodulin molecules express biantennary and high mannose type glycans based on the results of previous structural analyses (21). Such THP glycoforms would be expected to bind to concanavalin A-agarose (42). Thus differences between the current and previous preparations of uromodulin may be minimal.

The present investigation indicates that the O-glycans of THP change radically during pregnancy. This result infers that the glycosylation of THP could be regulated by specific pregnancy-related hormones. The systemic levels of both the estrogens and progesterone are substantially increased in gravid human females (43, 44). It is significant in this context to note that human steroid hormone receptors are present in the kidneys (45). In baboons, progesterone receptors are localized to the epithelial cells of the thick ascending limbs of the loop of Henle and the most proximal part of the distal convoluted tubule, the primary site of synthesis of THP in the human kidney (46). Therefore steroid hormonal stimulation occurring during pregnancy may specifically induce the expression of specific glycosyltransferases required to synthesize the unusual core 2 type O-glycans linked to uromodulin. Key enzymes that could be under hormonal regulation include the fucosyltransferase(s) essential for the synthesis of the sialyl Lewisx sequence (47) and the core 2 GlcNAc transferase essential for converting core 1 to core 2 type O-glycans (48). Other N-acetylglucosaminyltransferases essential for forming multivalent sialyl Lewisx structures may also be hormonally regulated in the epithelial cells that synthesize THP.

Despite extensive investigation, the precise physiological role(s) of THP and uromodulin have not yet been determined (22). However, the pregnancy-specific expression of differential THP glycoforms suggests a potential functional role during this process. In a previous study, we demonstrated that gender-specific changes in the glycosylation of glycodelin, a glycoprotein synthesized in both the male and female reproductive tract, led to completely different biological activities (49, 50). It is our current operating hypothesis that glycosylation plays a pivotal role in tailoring the function of a subset of glycoproteins to their gender-specific roles in reproduction. Structural and functional studies are under way to determine if THP/uromodulin is yet another glycoprotein that fits into this category.

    ACKNOWLEDGEMENTS

We are grateful for the help of Dr. Francis Bowe and Cian O'Gaora. We appreciate the assistance of Drs. Frank Lattanzio and Gerald Pepe for reviewing the manuscript.

    FOOTNOTES

* This work was supported by the Biotechnology and Biological Sciences Research Council and the Wellcome Trust Grants 030825 and 046294 (to A. D. and H. R. M.) and the National Institutes of Health Grants HD35652 (to G. F. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence may be addressed. Tel.: 001-757-446-5650; Fax: 001-757-624-2270; E-mail: gfc@borg.evms.edu.

|| To whom correspondence may be addressed. Tel.: 44-020-7594-5219; Fax: 44-020-7225-0458; E-mail: h.morris@ic.ac.uk.

** To whom correspondence may be addressed. Tel.: 44-020-7594-5219; Fax: 44-020-7225-0458; E-mail: a.dell@ic.ac. uk.

Published, JBC Papers in Press, April 18, 2000 DOI 10.1074/jbc.M001534200

    ABBREVIATIONS

The abbreviations used are: THP, Tamm-Horsfall glycoprotein; FAB-MS, fast atom bombardment-mass spectrometry; IL, interleukin.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Tamm, I., and Horsfall, F. L. (1952) J. Exp. Med. 95, 71-97
2. Tamm, I., and Horsfall, F. L. (1950) Proc. Soc. Exp. Biol. Med. 74, 108-114
3. Orskov, I., Ferencz, A., and Orskov, F. (1980) Lancet 1, 887
4. Orskov, I., Orskov, F., and Birch-Andersen, A. (1980) Infect. Immun. 27, 657-666
5. Mattey, M., and Naftalin, L. (1992) Experientia (Basel) 48, 975-980
6. Hoyer, J. R., and Seiler, M. W. (1979) Kidney Int. 16, 279-289
7. Adcock, E. W. D., Teasdale, T., August, C. S., Cox, S., Meschia, G., Ballaglia, T. C., and Naughton, M. A. (1973) Science 181, 845-847
8. Contractor, S. F., and Davies, H. (1973) Nat. New Biol. 243, 284-286
9. Muchmore, A. V., and Blaese, R. M. (1977) J. Immunol. 118, 881-886
10. Caldwell, J. L., Stites, D. P., and Fudenberg, H. H. (1975) J. Immunol. 115, 1249-1253
11. Muchmore, A. V., and Decker, J. M. (1985) Science 229, 479-481
12. Hession, C., Decker, J. M., Sherblom, A. P., Kumar, S., Yue, C. C., Mattaliano, R. J., Tizard, R., Kawashima, E., Schmeissner, U., Heletky, S., Chow, E. P., Burne, C. A., Shaw, A., and Muchmore, A. V. (1987) Science 237, 1479-1484
13. Pennica, D., Kohr, W. J., Kuang, W. J., Glaister, D., Aggarwal, B. B., Chen, E. Y., and Goeddel, D. V. (1987) Science 236, 83-88
14. Muchmore, A. V., and Decker, J. M. (1987) J. Immunol. 138, 2541-2546
15. Sherblom, A. P., Decker, J. M., and Muchmore, A. V. (1988) J. Biol. Chem. 263, 5418-5424
16. Sherblom, A. P., Sathyamoorthy, N., Decker, J. M., and Muchmore, A. V. (1989) J. Immunol 143, 939-944
17. Moonen, P., Gaffner, R., and Wingfield, P. (1988) FEBS Lett. 226, 314-318
18. Tandai-Hiruma, M., Endo, T., and Kobata, A. (1999) J. Biol. Chem. 274, 4459-4466
19. Dell, A., Khoo, K.-H., Panico, M., McDowell, R. A., Etienne, A. T., Reason, A. J., and Morris, H. R. (1993) in in Glycobiology: A Practical Approach (Fukuda, M. , and Kobata, A., eds) , pp. 187-222, Oxford University Press, Oxford
20. Albersheim, P., Nevins, D. J., English, P. D., and Karr, A. (1967) Carbohydr. Res. 5, 340-345
21. Hard, K., Van Zadelhoff, G., Moonen, P., Kamerling, J. P., and Vliegenthart, F. G. (1992) Eur. J. Biochem. 209, 895-915
22. Kumar, S. (1998) Eur. J. Clin. Invest. 28, 483-484
23. Afonso, A.-M. M., Charlwood, P. A., and Marshall, R. D. (1981) Carbohydr. Res. 89, 309-319
24. Smagula, R. M., Van Halbeek, H., Decker, J. M., Muchmore, A. V., Moody, C. E., and Sherblom, A. P. (1990) Glycoconj. J. 7, 609-624
25. Van Rooijen, J. J., Kamerling, J. P., and Vliegenthart, J. F. (1998) Glycobiology 8, 1065-1075
26. Van Rooijen, J. J., Kamerling, J. P., and Vliegenthart, J. F. (1998) Eur. J. Biochem. 256, 471-487
27. Van Rooijen, J. J., Voskamp, A. F., Kamerling, J. P., and Vliegenthart, J. F. (1999) Glycobiology 9, 21-30
28. Donald, A. S., Yates, A. D., Soh, C. P., Morgan, W. T., and Watkins, W. M. (1983) Biochem. Biophys. Res. Commun. 115, 625-631
29. Fukuda, M., Spooncer, E., Oates, J. E., Dell, A., and Klock, J. C. (1984) J. Biol. Chem. 259, 10925-10935
30. Mizoguchi, A., Takasaki, S., Maeda, S., and Kobata, A. (1984) J. Biol. Chem. 259, 11949-11957
31. Lowe, J. B., Stoolman, L. M., Nair, R. P., Larsen, R. D., Berhend, T. L., and Marks, R. M. (1990) Cell 63, 475-484
32. Phillips, M. L., Nudelman, E., Gaeta, F. C., Perez, M., Singhal, A. K., Hakomori, S., and Paulson, J. C. (1990) Science 250, 1130-1132
33. Tiemeyer, M., Swiedler, S. J., Ishihara, M., Moreland, M., Schweingruber, H., Hirtzer, P., and Brandley, B. K. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 1138-1142
34. Polley, M. J., Phillips, M. L., Wayner, E., Nudelman, E., Singhal, A. K., Hakomori, S., and Paulson, J. C. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6224-6228
35. Foxall, C., Watson, S. R., Dowbenko, D., Fennie, C., Lasky, L. A., Kiso, M., Hasegawa, A., Asa, D., and Brandley, B. K. (1992) J. Cell Biol. 117, 895-902
36. Pouyani, T., and Seed, B. (1995) Cell 83, 333-343
37. Wilkins, P. P., Moore, K. L., McEver, R. P., and Cummings, R. D. (1995) J. Biol. Chem. 270, 22677-22680
38. Imai, Y., Lasky, L. A., and Rosen, S. D. (1993) Nature 361, 555-557
39. Ellies, L. G., Tsuboi, S., Petryniak, B., Lowe, J. B., Fukuda, M., and Marth, J. D. (1998) Immunity 9, 881-890
40. Toma, G., Bates, J. M., Jr., and Kumar, S. (1994) Biochem. Biophys. Res. Commun. 200, 275-282
41. Yu, C. L., Lin, W. M., Liao, T. S., Tsai, C. Y., Sun, K. H., and Chen, K. H. (1992) Immunopharmacology 24, 181-190
42. Cummings, R. D., and Kornfeld, S. (1982) J. Biol. Chem. 257, 11235-11240
43. Tulchinsky, D., Hobel, C. J., Yeager, E., and Marshall, J. R. (1972) Am. J. Obstet. Gynecol. 112, 1095-1100
44. Tulchinsky, D., and Hobel, C. J. (1973) Am. J. Obstet. Gynecol. 117, 884-893
45. Concolino, G., Marocchi, A., Concolino, F., Sciarra, F., Di Silverio, F., and Conti, C. (1976) J. Steroid Biochem. 7, 831-835
46. Weaker, F. J., Herbert, D. C., and Sheridan, P. J. (1984) J. Urol. 132, 792-794
47. Maly, P., Thall, A., Petryniak, B., Rogers, C. E., Smith, P. L., Marks, R. M., Kelly, R. J., Gersten, K. M., Cheng, G., Saunders, T. L., Camper, S. A., Camphausen, R. T., Sullivan, F. X., Isogai, Y., Hindsgaul, O., von Andrian, U. H., and Lowe, J. B. (1996) Cell 86, 643-653
48. Bierhuizen, M. F., and Fukuda, M. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9326-9330
49. Dell, A., Morris, H. R., Easton, R. L., Panico, M., Patankar, M., Oehniger, S., Koistinen, R., Koistinen, H., Seppala, M., and Clark, G. F. (1995) J. Biol. Chem. 270, 24116-24126
50. Morris, H. R., Dell, A., Easton, R. L., Panico, M., Koistinen, H., Koistinen, R., Oehninger, S., Patankar, M. S., Seppala, M., and Clark, G. F. (1996) J. Biol. Chem. 271, 32159-32167


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
K. Klisch, E. Jeanrond, P.-C. Pang, A. Pich, G. Schuler, V. Dantzer, M. P Kowalewski, and A. Dell
A Tetraantennary Glycan with Bisecting N-Acetylglucosamine and the Sda Antigen is the Predominant N-Glycan on Bovine Pregnancy-Associated Glycoproteins
Glycobiology, January 1, 2008; 18(1): 42 - 52.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Matousovic, J. Novak, T. Yanagihara, M. Tomana, Z. Moldoveanu, R. Kulhavy, B. A. Julian, K. Konecny, and J. Mestecky
IgA-containing immune complexes in the urine of IgA nephropathy patients
Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2478 - 2484.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
P. F. Rohfritsch, M. Rinnbauer, J. F.G. Vliegenthart, and J. P. Kamerling
Donor specificity in the glycosylation of Tamm-Horsfall glycoprotein: Conservation of the Sda determinant in pairs of twins
Glycobiology, April 1, 2004; 14(4): 365 - 372.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Kui Wong, R. L. Easton, M. Panico, M. Sutton-Smith, J. C. Morrison, F. A. Lattanzio, H. R. Morris, G. F. Clark, A. Dell, and M. S. Patankar
Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125
J. Biol. Chem., August 1, 2003; 278(31): 28619 - 28634.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
F. D. Menozzi, A.-S. Debrie, J.-P. Tissier, C. Locht, K. Pethe, and D. Raze
Interaction of human Tamm-Horsfall glycoprotein with Bordetella pertussis toxin
Microbiology, April 1, 2002; 148(4): 1193 - 1201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
X. Zhu, J. Cheng, J. Gao, H. Lepor, Z.-T. Zhang, J. Pak, and X.-R. Wu
Isolation of mouse THP gene promoter and demonstration of its kidney-specific activity in transgenic mice
Am J Physiol Renal Physiol, April 1, 2002; 282(4): F608 - F617.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. Dell and H. R. Morris
Glycoprotein Structure Determination by Mass Spectrometry
Science, March 23, 2001; 291(5512): 2351 - 2356.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/29/21928    most recent
M001534200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services